LSE Health, Department of Health Policy, London School of Economics and Political Science, London, United Kingdom; Department of International Health, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.
LSE Health, Department of Health Policy, London School of Economics and Political Science, London, United Kingdom; Department of International Health, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; European Observatory on Health Systems and Policies, World Health Organization, London, United Kingdom.
Vaccine. 2023 Apr 24;41(17):2804-2810. doi: 10.1016/j.vaccine.2023.03.036. Epub 2023 Mar 22.
The COVID-19 pandemic highlighted the fragmented nature of governmental policy decisions in Europe. However, the extent to which COVID-19 vaccination policies differed between European countries remains unclear. Here, we mapped the COVID-19 vaccination policies that were in effect in January 2022 as well as booster regulations in April 2022 in Austria, Denmark, England, France, Germany, Ireland, Italy, the Netherlands, Poland, and Spain.
National public health and health policy experts from these ten European nations developed and completed an electronic questionnaire. The questionnaire included a series of questions that addressed six critical components of vaccine implementation, including (1) authorization, (2) prioritization, (3) procurement and distribution, (4) data collection, (5) administration, and (6) mandate requirements.
Our findings revealed significant variations in COVID-19 vaccination policies across Europe. We observed critical differences in COVID-19 vaccine formulations authorized for use, as well as the specific groups that were provided with priority access. We also identified discrepancies in how vaccination-related data were recorded in each country and what vaccination requirements were implemented.
Each of the ten European nations surveyed in this study reported different COVID-19 vaccination policies. These differences complicated efforts to provide a coordinated pandemic response. These findings might alert policymakers in Europe of the need to coordinate their efforts to avoid fostering divergent and socially disruptive policies.
COVID-19 大流行凸显了欧洲各国政府政策决策的分散性。然而,COVID-19 疫苗接种政策在欧洲各国之间的差异程度仍不清楚。在这里,我们绘制了 2022 年 1 月生效的 COVID-19 疫苗接种政策以及 2022 年 4 月加强针接种规定,涵盖奥地利、丹麦、英国、法国、德国、爱尔兰、意大利、荷兰、波兰和西班牙这十个欧洲国家。
来自这十个欧洲国家的国家公共卫生和卫生政策专家制定并完成了一份电子问卷。问卷包含了一系列问题,涉及疫苗实施的六个关键组成部分,包括(1)授权、(2)优先级、(3)采购和分发、(4)数据收集、(5)管理和(6)授权要求。
我们的研究结果显示,欧洲各国的 COVID-19 疫苗接种政策存在显著差异。我们观察到 COVID-19 疫苗授权使用的配方以及优先获得疫苗的特定群体方面存在重大差异。我们还发现,每个国家在记录与疫苗接种相关的数据以及实施哪些疫苗接种要求方面存在差异。
本研究调查的十个欧洲国家都报告了不同的 COVID-19 疫苗接种政策。这些差异使协调大流行应对措施变得复杂。这些发现可能会提醒欧洲的政策制定者协调努力的必要性,以避免助长分歧和对社会具有破坏性的政策。